Dabigat (Dabigatran Etexilate) is an anticoagulant medication used to reduce the risk of stroke and blood clots in patients with non-valvular atrial fibrillation. It works by inhibiting thrombin, an enzyme involved in blood clotting, thereby preventing the formation of clots.
Dabigatran is a direct thrombin inhibitor that affects the coagulation cascade, which is crucial in the formation of blood clots. By blocking thrombin, Dabigat prevents the conversion of fibrinogen to fibrin, a key step in the clotting process.
The typical dosage for Dabigat is determined by the prescribing physician based on individual patient factors such as renal function. It is usually taken orally, with or without food, and should be swallowed whole.
Common side effects may include:
Patients should seek immediate medical attention if they experience severe bleeding, unusual bruising, or signs of an allergic reaction.
Before taking Dabigat, patients should inform their healthcare provider about any medical conditions, particularly kidney issues, and any other medications they are taking to avoid potential interactions.
Dabigat should be stored at room temperature, away from moisture and heat. Keep out of reach of children.
Always consult a healthcare professional for personalized advice and to ensure that Dabigat is the right medication for your condition.